Document is current
Any future updates will be listed below
-
Authors
Pramesh, C. S. https://orcid.org/0000-0002-3635-0083
Babu, Giridhara R.
Basu, Joyeeta
Bhushan, Indu
Booth, Christopher M.
Chinnaswamy, Girish
Guleria, Randeep
Kalantri, S. P.
Kang, Gagandeep
Mohan, Pavitra
Mor, Nachiket https://orcid.org/0000-0001-8136-2844
Pai, Madhukar https://orcid.org/0000-0003-3667-4536
Prakash, Manu
Rupali, Priscilla
Sampathkumar, Priya
Sengar, Manju
Sullivan, Richard
Ranganathan, Priya
- License Information
-
More Information
Article History
First Online: 5 July 2021
Competing interests
: G.K. is vice-chair of the board for the Coalition for Epidemic Preparedness Innovations, director of MSD Wellcome Trust Hilleman Laboratories, director of the Ignite Life Science Foundation, a member of the scientific advisory board of Mynvax, a member of the scientific advisory board for mRNA vaccines at Cipla (all of which are honorary, except Hilleman Laboratories, where G.K. is a Wellcome Trust–nominated Director and receives an honorarium that is transferred to her institution). M. Pai receives funding from the Bill & Melinda Gates Foundation for tuberculosis research.
Free to read: This content has been made available to all.
